Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors

COMMACK, N.Y., July 2, 2014 /PRNewswire/ -- It is a great honor for Avery Biomedical Devices, Inc. (ABD) to announce the appointment of the world-renowned Thoracic and Cardiovascular surgeon, Mark E Ginsburg, M.D., to its Board of Directors.

Dr. Ginsburg, with over 34 years of experience, is currently practicing at two facilities: NY Presbyterian Hospital and Good Samaritan Regional Medical Center. Dr. Ginsburg has been implanting the Avery Breathing Pacemaker since the late 1980's and is considered an expert in the implantation of the Avery System. In addition, he has travelled the world to implant the Avery System in those patients who are unable to travel to the United States. He has published numerous scientific papers and books such as Lung Volume Reduction Surgery (LVRS) and Emphysema Treatments. In addition, he was lead investigator on several clinical trials.

Martin Dobelle, CEO, states, "We are humbled to have Dr. Ginsburg join our Board of Directors. His experience and expertise will be invaluable to the future growth of ABD."

Dr. Ginsburg states, "It is a privilege to serve on the Board of Directors of ABD. This company has served the world's need in diaphragm pacing. Exciting new products are under development in this and related arenas as well. I look forward to providing medical and surgical input to the Board."

ABOUT ABD

Avery Biomedical Devices, Inc. is a privately-held company located on Long Island, New York. It manufactures the Avery Breathing Pacemaker System: an implanted diaphragmatic pacemaker which is used to free many quadriplegics, central sleep apnea and diaphragm paralysis patients from mechanical ventilation. Most patients strongly prefer pacing to mechanical ventilation for reasons such as breathing and speech patterns, ease of eating and drinking and improved sense of smell. Since breathing pacemakers costs far less than mechanical ventilation and do not use percutaneous wire that pass through the skin (infection risk), it is the more prudent choice for life support.

The Avery Breathing Pacemaker is the only device of its kind with premarket approval from the USFDA and CE marking privileges under the European Active Implantable Medical Device Directive. Should you know of a patient with quadriplegia, central sleep apnea, diaphragm paralysis or another condition that may benefit from an Avery Breathing Pacemaker, please contact us.

CONTACT:
Martin D. Dobelle, CEO
631-864-1600
www.averybiomedical.com

SOURCE Avery Biomedical Devices, Inc.

RELATED LINKS
http://www.averybiomedical.com/

reade more... Résuméabuiyad

Secure Identity & Biometrics Association (SIBA) Announces Its Board of Directors, Comprised of the Very Best in Commercial and Strategic Leadership and Identity Expertise

Janice Kephart, SIBA founder and CEO. (PRNewsFoto/Secure Identity & Biometrics Association)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";WASHINGTON, April 9, 2014 /PRNewswire/ -- The Secure Identity & Biometrics Association (SIBA), a non-profit association established in February 2014 to encourage use of solutions that protect and secure identity across private and public platforms, today announces its board members. The new SIBA board represents proven expertise in identity management and biometric solutions, high technology government relations and commercialization, and the defense, intelligence and homeland security communities. "I am so pleased with the diverse and highly relevant experience on the SIBA board," said Janice Kephart, SIBA CEO. "We are already covering new thought leadership ground on the most pressing secure identity and biometric issues, and with a board like this, we will have the ability to reach audiences in business, government and consumer level in a manner unprecedented to date."

Photo - http://photos.prnewswire.com/prnh/20140409/PH01124-a

Logo - http://photos.prnewswire.com/prnh/20140409/PH01124LOGO-b

SIBA board members are:

Jim Annulis, President and CEO, ProQual-I.T., Inc. Ernest Baynard, President, Meridian Hill Strategies Inc. Michael Dougherty, Director of Law Enforcement Solutions, Raytheon Lester Quintana, Senior Vice President, Cellucci Associates Paul Schuepp, President and CEO, Animetrics Matthew Young, Manager, Biometric and Identity Intelligence Solutions, Sotera Defense SolutionsSIBA strategic advisors are:

Reed Stager, President, Five Peaks Group Horace Kephart, former President and CEO, G.O. Carlson Inc. Paul Schuepp and Jim Annulis said this about serving on the SIBA board:

"Animetrics enthusiastically joined SIBA as a founding member. Janice Kephart's timing establishing SIBA, with the current tsunami of activity and demand for the biometric industry and technology providers, was a perfect opportunity for Animetrics to play a significant role in our industry's advocacy and thought leadership. SIBA has created the forum for responsible industry organizations to participate in creation of consensus, economic security, policy and legislative change." - Paul Schuepp

"Being an entrepreneur, I realize that novel concepts keep business and technology moving forward - to challenge the status quo, enabling better ideas to root and flourish. That's not easy to do, but it's    necessary. After my first discussion with Janice Kephart, it was evident that she possessed what I consider to be the three necessary characteristics of a change agent: knowledge, influence, and guts. With Janice at SIBA's helm, I think we can introduce new identity management solutions and help people understand how those solutions can improve their lives." - Jim Annulis

Ernest Baynard states: "The global identity management and biometrics community is at a critical crossroads right now with new use cases launching worldwide while decision makers here in the United States continue to make critical decisions regarding the use of new technologies here at home. It is essential that, as a nation, we get this right on both the facts and the policy -- I am confident that SIBA will provide an impactful and insightful voice to this important debate."

Emerging technology and commercialization strategist Dr. Thomas Cellucci, Ph.D., MBA Chairman & CEO of Cellucci Associates, Inc., says of SIBA's potential: "As one who frequently works with the intelligence community, I see great value in the next generation of biometric and identity systems that provide innovation." Cellucci is author of the best seller An Innovative Guide to Public-Private Partnerships. Lester Quintana's view: "Biometrics and identity management are at the core of emerging technologies for all sectors, including global markets. Cellucci Associates believes SIBA is the forum to provide the essential leadership in a dynamic market."

Matthew Young approaches SIBA from the perspective of technology integration and interoperability. "SIBA is well positioned to enable the biometrics industry to integrate into the commercial and government sectors by bringing together SMEs, business leaders, and expertise in legal and policy implications. SIBA has a key responsibility to provide sufficient awareness and information for decision makers and consumers alike, allowing them to determine the appropriate role for biometric and identity technology."

SIBA is a group of vendors and other stakeholders with a common interest in proactive thought leadership, communications and government relations. Its mission is to create awareness and promote the value of secure identity technologies and biometric solutions that effectively protect and secure individuals from identity threats as well as protect and secure facilities, organizations and governments.  

For more on SIBA CEO Janice Kephart, see the press release announcing SIBA's establishment here.

http://www.sibassoc.org

Contact:
Janice Kephart
703-581-7721

Read more news from Secure Identity and Biometrics Association.

SOURCE Secure Identity & Biometrics Association

RELATED LINKS
http://www.sibassoc.org

reade more... Résuméabuiyad

Secure Identity & Biometrics Association (SIBA) Announces Its Board of Directors, Comprised of the Very Best in Commercial and Strategic Leadership and Identity Expertise

Janice Kephart, SIBA founder and CEO. (PRNewsFoto/Secure Identity & Biometrics Association)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";WASHINGTON, April 9, 2014 /PRNewswire/ -- The Secure Identity & Biometrics Association (SIBA), a non-profit association established in February 2014 to encourage use of solutions that protect and secure identity across private and public platforms, today announces its board members. The new SIBA board represents proven expertise in identity management and biometric solutions, high technology government relations and commercialization, and the defense, intelligence and homeland security communities. "I am so pleased with the diverse and highly relevant experience on the SIBA board," said Janice Kephart, SIBA CEO. "We are already covering new thought leadership ground on the most pressing secure identity and biometric issues, and with a board like this, we will have the ability to reach audiences in business, government and consumer level in a manner unprecedented to date."

Photo - http://photos.prnewswire.com/prnh/20140409/PH01124-a

Logo - http://photos.prnewswire.com/prnh/20140409/PH01124LOGO-b

SIBA board members are:

Jim Annulis, President and CEO, ProQual-I.T., Inc. Ernest Baynard, President, Meridian Hill Strategies Inc. Michael Dougherty, Director of Law Enforcement Solutions, Raytheon Lester Quintana, Senior Vice President, Cellucci Associates Paul Schuepp, President and CEO, Animetrics Matthew Young, Manager, Biometric and Identity Intelligence Solutions, Sotera Defense SolutionsSIBA strategic advisors are:

Reed Stager, President, Five Peaks Group Horace Kephart, former President and CEO, G.O. Carlson Inc. Paul Schuepp and Jim Annulis said this about serving on the SIBA board:

"Animetrics enthusiastically joined SIBA as a founding member. Janice Kephart's timing establishing SIBA, with the current tsunami of activity and demand for the biometric industry and technology providers, was a perfect opportunity for Animetrics to play a significant role in our industry's advocacy and thought leadership. SIBA has created the forum for responsible industry organizations to participate in creation of consensus, economic security, policy and legislative change." - Paul Schuepp

"Being an entrepreneur, I realize that novel concepts keep business and technology moving forward - to challenge the status quo, enabling better ideas to root and flourish. That's not easy to do, but it's    necessary. After my first discussion with Janice Kephart, it was evident that she possessed what I consider to be the three necessary characteristics of a change agent: knowledge, influence, and guts. With Janice at SIBA's helm, I think we can introduce new identity management solutions and help people understand how those solutions can improve their lives." - Jim Annulis

Ernest Baynard states: "The global identity management and biometrics community is at a critical crossroads right now with new use cases launching worldwide while decision makers here in the United States continue to make critical decisions regarding the use of new technologies here at home. It is essential that, as a nation, we get this right on both the facts and the policy -- I am confident that SIBA will provide an impactful and insightful voice to this important debate."

Emerging technology and commercialization strategist Dr. Thomas Cellucci, Ph.D., MBA Chairman & CEO of Cellucci Associates, Inc., says of SIBA's potential: "As one who frequently works with the intelligence community, I see great value in the next generation of biometric and identity systems that provide innovation." Cellucci is author of the best seller An Innovative Guide to Public-Private Partnerships. Lester Quintana's view: "Biometrics and identity management are at the core of emerging technologies for all sectors, including global markets. Cellucci Associates believes SIBA is the forum to provide the essential leadership in a dynamic market."

Matthew Young approaches SIBA from the perspective of technology integration and interoperability. "SIBA is well positioned to enable the biometrics industry to integrate into the commercial and government sectors by bringing together SMEs, business leaders, and expertise in legal and policy implications. SIBA has a key responsibility to provide sufficient awareness and information for decision makers and consumers alike, allowing them to determine the appropriate role for biometric and identity technology."

SIBA is a group of vendors and other stakeholders with a common interest in proactive thought leadership, communications and government relations. Its mission is to create awareness and promote the value of secure identity technologies and biometric solutions that effectively protect and secure individuals from identity threats as well as protect and secure facilities, organizations and governments.  

For more on SIBA CEO Janice Kephart, see the press release announcing SIBA's establishment here.

http://www.sibassoc.org

Contact:
Janice Kephart
703-581-7721

Read more news from Secure Identity and Biometrics Association.

SOURCE Secure Identity & Biometrics Association

RELATED LINKS
http://www.sibassoc.org

reade more... Résuméabuiyad

Avanir Pharmaceuticals Announces Appointment of Mark Corrigan to Board of Directors

Avanir Pharmaceuticals, Inc. (PRNewsFoto/Avanir Pharmaceuticals, Inc.)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";ALISO VIEJO, Calif., March 19, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the appointment of Dr. Mark Corrigan to the company's board of directors. Dr. Corrigan, a seasoned life sciences executive joins Avanir's board with broad healthcare industry experience.

Dr. Corrigan currently serves as president and chief executive officer of Zalicus Inc. a public biopharmaceutical company, a position he has held since January 2010. He has also served as a director of Zalicus and its progenitor companies since December 2006. Prior to Zalicus, Dr. Corrigan served as executive vice president, research and development at Sepracor, Inc. (now known as Sunovion Pharmaceuticals, Inc.). Prior to joining Sepracor, Dr. Corrigan spent 10 years with Pharmacia & Upjohn, a pharmaceutical company acquired by Pfizer, Inc. in 2003, most recently as group vice president of Global Clinical Research and Experimental Medicine. Prior to joining the pharmaceutical industry, Dr. Corrigan spent five years in academic research at the University of North Carolina Medical School, focusing on psychoneuroendocrinology. Dr. Corrigan has also been a member of the board of directors and audit committee of Cubist Pharmaceuticals, Inc. since June 2008. Dr. Corrigan holds a B.A. and an M.D. from the University of Virginia and subsequently received specialty training in Psychiatry at Cornell and Maine Medical Center.

"It is a pleasure to welcome Mark to the Avanir Board," commented Craig Wheeler, chairman of the board, "Mark brings many years of experience in the healthcare sector combined with a deep knowledge of CNS research and development together with broad experience in guiding the growth of biopharma companies.  I look forward to the insights he will bring to our board and to working with him as Avanir pursues its growth initiatives."

About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in the United States and other countries.

©2014 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Avanir Investor & Media Contact
Ian Clements, PhD
ir@avanir.com
+1 (949) 389-6700

Joey Fleury, BrewLife
jfleury@brewlife.com
+1 (415) 946-1090

Logo - http://photos.prnewswire.com/prnh/20130207/LA55901LOGO

SOURCE Avanir Pharmaceuticals, Inc.

RELATED LINKS
www.avanir.com

reade more... Résuméabuiyad